cilta-cel

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Anthropic is reportedly considering another advanced Claude model as competition with OpenAI intensifies across enterprise artificial-intelligence workloads. Representative image.

Anthropic weighs another Claude model as OpenAI Astra intensifies enterprise AI race

Arista Networks is expanding its EOS-based networking platform across 1.6-terabit Ethernet AI fabrics, hyperscale data centers, CloudVision and enterprise connectivity as artificial intelligence reshapes network architecture. Representative image.

Arista Networks company profile: How EOS and Ethernet are powering its AI data center expansion

Eli Lilly’s retatrutide moves closer to a planned 2027 U.S. filing after completing its core Phase 3 programme for obesity, knee pain and sleep apnea. Representative image.

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

India and Canada are accelerating CEPA negotiations as LNG, nuclear energy and critical minerals become central to their expanding economic relationship. Representative image.

Canada targets India trade deal by year-end as LNG, nuclear and critical minerals talks deepen

Legend Biotech (NASDAQ: LEGN) CARVYKTI scaling meets LB2102 solid tumor signal

Legend Biotech (NASDAQ: LEGN) printed 62% CARVYKTI growth and a solid tumor CAR-T signal. The 2026 profitability target is the next real test.

bySrinath

June 23, 2026

Legend Biotech soars 42% on ASCO data as CAR-T momentum extends from blood cancers toward solid tumors

Legend Biotech soared 42% on ASCO data: a survival readout for myeloma CAR-T CARVYKTI plus early solid-tumor results for LB2102. Big ramp, but still loss-making.

byVenkatesh

June 3, 2026

The Latest

Anthropic weighs another Claude model as OpenAI Astra intensifies enterprise AI race

Arista Networks company profile: How EOS and Ethernet are powering its AI data center expansion

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

Canada targets India trade deal by year-end as LNG, nuclear and critical minerals talks deepen

Legend Biotech (NASDAQ: LEGN) CARVYKTI scaling meets LB2102 solid tumor signal

Legend Biotech soars 42% on ASCO data as CAR-T momentum extends from blood cancers toward solid tumors

Anthropic weighs another Claude model as OpenAI Astra intensifies enterprise AI race

Arista Networks company profile: How EOS and Ethernet are powering its AI data center expansion

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

Canada targets India trade deal by year-end as LNG, nuclear and critical minerals talks deepen

Trump White House media ban takes effect as MS NOW journalists are turned away

Smoke rises near Riyadh airport after Saudi aerial alerts as Houthi conflict escalates

India and Pakistan trade accusations after INS Kolkata collides with PNS Hunain

Kohat police mosque attack death toll reaches 31 after 20-hour security operation